ARK was recognized by Fund Intelligence during The Mutual Fund Industry and ETF Awards 2019 for the ETF Suite of the Year, Active ETF of the Year (ARKK),
| # | Company | $ | % |
|---|---|---|---|
| 1 | TEMPUS AI | TEM | 12 |
| 2 | CRISPR THERAPEUTICS AG | CRSP | 9.76 |
| 3 | TWIST BIOSCIENCE | TWST | 5.1 |
| 4 | RECURSION PHARMACEUTICALS | RXRX | 5.03 |
| 5 | NATERA | NTRA | 4.53 |
| 6 | PERSONALIS | PSNL | 4.41 |
| 7 | GUARDANT HEALTH | GH | 4.12 |
| 8 | BEAM THERAPEUTICS | BEAM | 3.96 |
| 9 | 10X GENOMICS | TXG | 3.94 |
| 10 | ADAPTIVE BIOTECHNOLOGIES | ADPT | 3.9 |
| 11 | IONIS PHARMACEUTICALS | IONS | 3.63 |
| 12 | VERACYTE | VCYT | 3.42 |
| 13 | ILLUMINA | ILMN | 3.39 |
| 14 | SCHRODINGER | SDGR | 3.26 |
| 15 | INTELLIA THERAPEUTICS | NTLA | 3.06 |
| 16 | ARCTURUS THERAPEUTICS HOLDIN | ARCT | 2.89 |
| 17 | CAREDX | CDNA | 2.85 |
| 18 | ABSCI | ABSI | 2.81 |
| 19 | PRIME MEDICINE | PRME | 1.85 |
| 20 | EXACT SCIENCES | EXAS | 1.23 |
| 21 | NURIX THERAPEUTICS | NRIX | 1.23 |
| 22 | AMGEN | AMGN | 1.22 |
| 23 | PACIFIC BIOSCIENCES OF CALIF | PACB | 1.21 |
| 24 | INCYTE | INCY | 1.15 |
| 25 | 908 DEVICES | MASS | 1.1 |
| 26 | VEEVA SYSTEMS | VEEV | 1.05 |
| 27 | COMPASS PATHWAYS PLC | CMPS | 1.02 |
| 28 | BUTTERFLY NETWORK | BFLY | 0.96 |
| 29 | VERTEX PHARMACEUTICALS | VRTX | 0.95 |
| 30 | QUANTUM-SI | QSI | 0.9 |
| 31 | CARIS LIFE SCIENCES | CAI | 0.76 |
| 32 | GENEDX HOLDINGS | WGS | 0.75 |
| 33 | CERUS | CERS | 0.74 |
| 34 | ATAI LIFE SCIENCES NV | ATAI | 0.67 |
| 35 | REGENERON PHARMACEUTICALS | REGN | 0.65 |
| 36 | STANDARD BIOTOOLS | LAB | 0.39 |